Background: Parathyroid hormone (PTH) monitoring during the surgical procedure can confirm the removal of all hyperfunctioning parathyroid tissue, as the half-life of PTH is approximately 5 min.

U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for YORVIPATH in the United States for the ...

How much do you know about these eight hormones, which play a huge role in how we feel? The post Read up on the hormones that ...

Excess parathyroid hormone due to over activity of parathyroid glands, four pea-sized glands located at the back of thyroid gland. Symptoms include loss of appetite, increased thirst and urination, ...

Parathyroid hormone (PTH) is secreted from the parathyroid glands (four circles). A new auxiliary source of PTH has been located in the thymus. PTH increases mobilization of calcium (Ca) from bone ...

Ascendis Pharma said the Food and Drug Administration has granted it seven years of orphan drug exclusivity for Yorvipath as a treatment for hypoparathyroidism in adults. Yorvipath, or ...

In a trial emulation of 40,231 veterans with PHPT and no history of depression, the 5-year weighted cumulative incidence of ...

(Reuters) - MBX Biosciences, which is developing peptide therapies for treating endocrine and metabolic disorders, including ...

Calcimimetics suppress the secretion of parathyroid hormone by sensitizing the parathyroid calcium receptor to serum calcium. Cinacalcet (Sensipar ® /Mimpara ®, Amgen Inc., Thousand Oaks ...

Age-related musculoskeletal diseases are a significant public health concern that critically impacts the motor functions and the quality of life in the elderly. The musculoskeletal system supports the ...

The UAE BioTech Symposium will be hosted in partnership with AmCham Abu Dhabi's BioTech Committee and Masdar City <li /> T ...

(RTTNews) - Ascendis Pharma A/S (ASND) said that the U.S. Food & Drug Administration has granted Orphan Drug exclusivity to YORVIPATH (palopegteriparatide, developed as TransCon PTH), providing seven ...